Oncology News

The FDA granted orphan drug designation to TST001 for treatment of gastric and gastroesophageal junction cancers, according to the agent’s manufacturer.

According to a study published in Therapeutic Advances in Gastroenterology, internal endoscopic drainage should be the first line endoscopic treatment of anastomotic fistulas when possible.

The FDA issued a complete response letter to Incyte indicating it cannot approve the company’s biologics license application that seeks approval of retifanlimab for certain patients with anal cancer.

Bristol Myers Squibb in consultation with the FDA voluntarily withdrew the indication for nivolumab as monotherapy for patients with hepatocellular carcinoma previously treated with sorafenib.

Healio Gastroenterology presents the following reports on recent news in COVID-19.

For patients with recurrent and metastatic pancreatic cancer who received chemotherapy as a first-line treatment, early tumor shrinkage correlated with an improved rate of progression-free survival and overall survival.

Multitarget fecal immunochemical testing yielded better diagnostic accuracy in the detection of advanced adenomas compared with basic FIT, according to research published in Annals of Internal Medicine.

Healio Gastroenterology presents the following report on the top peer-tested stories in June.

The American Gastroenterological Association published a clinical practice update to describe the role of medications for the chemoprevention of colorectal neoplasia.

Alcohol consumption appeared linked to more than 740,000 new cancer diagnoses in 2020, equivalent to 4% of cases worldwide.